StockStory.org on MSN

Winners and losers of Q4: Insulet (NASDAQ:PODD) vs the rest of the patient monitoring stocks

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet ...

2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, ...
Medical Device and Diagnostic Industry (MD+DI)

MiniMed Emerges as the Only Full-Stack Diabetes Tech Player in a $18B Market

Discover how MiniMed's full-stack diabetes technology and global reach post-IPO could transform a rapidly growing $18B ...
Young and the Invested on MSN

Growth stocks are hurting, but Wall Street still loves these 7 picks

This article discusses the best growth stocks to buy right now.
MassDevice

Abbott joins $575M funding round for wearable maker Whoop

Whoop announced that it raised $575 million in a Series G financing round with medtech giant Abbott taking part.

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

Experience From Brazilian and Australian Clinical Trials Positions the Company to Submit Investigational Device Exemption (IDE) to FDA for Novel CBGM Technology in Q2 2026RUTHERFORD, N.J., March 27, ...